Literature DB >> 2559087

Changes in gap junction protein (connexin 32) gene expression during rat liver carcinogenesis.

D J Fitzgerald1, M Mesnil, M Oyamada, H Tsuda, N Ito, H Yamasaki.   

Abstract

A rat liver gap junction (GJ) cDNA probe that detects mRNA encoding the 32 Kd GJ-protein (connexin 32) was employed to study GJ-protein gene expression in rat liver tumors induced by a single exposure to diethylnitrosamine (DEN) followed by exposure to 2-acetylaminofluorene (AAF)/CCl4/AAF or induced by systemic administration of N-ethyl-N-hydroxyethylnitrosamine (EHEN). All carcinomas generated by these carcinogens showed markedly reduced levels of GJ-protein mRNA. This may indicate that GJ-protein levels and gap-junctional intercellular communication (GJIC) capacity are also severely compromised. Moreover, all hyperplastic nodules also showed a reduced level of GJ-protein mRNA. Taken together with our earlier finding that the liver tumor promoter phenobarbital inhibits GJ-protein gene expression, these results suggest that deranged GJIC is a relatively early event in liver multistage carcinogenesis. A range of other cDNA probes was also used to characterize gene expression in the DEN-induced tumors. Induction of expression was seen for glutathione S-transferase (placental form) (GST-P), gamma-glutamyltranspeptidase (GGT), and c-raf but not for c-Ha-ras or c-myc.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2559087     DOI: 10.1002/jcb.240410206

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  11 in total

Review 1.  Hepatic neoplasia: reflections and ruminations.

Authors:  K Aterman
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

2.  Combinational treatment of gap junctional activator and tamoxifen in breast cancer cells.

Authors:  Gunjan Gakhar; Duy H Hua; Thu Annelise Nguyen
Journal:  Anticancer Drugs       Date:  2010-01       Impact factor: 2.248

3.  Morphological alterations of gap junctions in phalloidin-treated rat livers.

Authors:  M Ohta; T Okanoue; S Takami; Y Nagao; T Mori; N Hori; M Oka; K Kagawa; K Kashima
Journal:  J Gastroenterol       Date:  1994-04       Impact factor: 7.527

4.  The gap junctional intercellular communication is no prerequisite for the stabilization of xenobiotic metabolizing enzyme activities in primary rat liver parenchymal cells in vitro.

Authors:  M Traiser; B Diener; D Utesch; F Oesch
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-04       Impact factor: 2.416

Review 5.  Cell culture assays for chemicals with tumor-promoting or tumor-inhibiting activity based on the modulation of intercellular communication.

Authors:  I V Budunova; G M Williams
Journal:  Cell Biol Toxicol       Date:  1994-04       Impact factor: 6.691

6.  Basal promoter of the rat connexin 32 gene: identification and characterization of an essential element and its DNA-binding protein.

Authors:  S Bai; A Schoenfeld; A Pietrangelo; R D Burk
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

Review 7.  Gap junctional intercellular communication and cell proliferation during rat liver carcinogenesis.

Authors:  H Yamasaki; V Krutovskikh; M Mesnil; A Columbano; H Tsuda; N Ito
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

Review 8.  Aberrant expression and function of gap junctions during carcinogenesis.

Authors:  H Yamasaki
Journal:  Environ Health Perspect       Date:  1991-06       Impact factor: 9.031

9.  Changes in expression of connexin 32, bile canaliculus-like structures, and localization of alkaline phosphatase in primary cultures of fetal rat hepatocytes.

Authors:  Shoko Fukazawa; Kohsuke Chida; Meiko Taguchi; Akihiro Takeuchi; Noriaki Ikeda
Journal:  Acta Histochem Cytochem       Date:  2013-01-11       Impact factor: 1.938

10.  Differential changes in expression of gap junction proteins connexin 26 and 32 during hepatocarcinogenesis in rats.

Authors:  H Sakamoto; M Oyamada; K Enomoto; M Mori
Journal:  Jpn J Cancer Res       Date:  1992-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.